Back to Directory

Shawn Chiambah

Email

shawn.chiambah@nih.gov

Institution

Pharmaceutical Affairs Branch, Division of AIDS

Address

Division of AIDS/OCSO/NIAID/NIH
5601 Fishers Lane
Bethesda, MD 20892-3593
USA

Request an Update

Affiliated Studies

IMPAACT 2051: Phase II Study of the Pharmacokinetics, Safety, Tolerability, and Anti-Mycobacterial Activity of Pretomanid with Bedaquiline and Linezolid, with or without Moxifloxacin, in Children with Rifampicin-Resistant Tuberculosis

DAIDS Number

Research Area

Study Status

IMPAACT 2034: Phase 1 Study of the Pharmacokinetics, Safety, and Acceptability of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children with Rifampicin-Resistant Tuberculosis

DAIDS Number

Research Area

Study Status

Participants Off Study and Primary Analysis Completed

IMPAACT 2024 : Phase I/II Dose Finding, Safety and Tolerability Study of Daily Rifapentine Combined with Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age with and without HIV.

DAIDS Number

Research Area

Study Status

Open to Accrual